Statistical analysis

MK Machiko Kai
HH Hayato Hikita
MK Maesaka Kazuki
YT Yuki Tahata
KS Kazuma Shinkai
AD Akira Doi
KO Kazuyoshi Ohkawa
MM Masanori Miyazaki
HI Hisashi Ishida
KM Kengo Matsumoto
YN Yasutoshi Nozaki
TY Takayuki Yakushijin
RS Ryotaro Sakamori
AK Akira Kaneko
SI Sadaharu Iio
TN Takatoshi Nawa
NK Naruyasu Kakita
NM Naoki Morishita
NH Naoki Hiramatsu
TU Takeo Usui
KI Kazuho Imanaka
YD Yoshinori Doi
MS Mitsuru Sakakibara
YY Yuichi Yoshida
TO Tsugiko Oze
TK Takahiro Kodama
TT Tomohide Tatsumi
TT Tetsuo Takehara
request Request a Protocol
ask Ask a question
Favorite

Patient characteristics were expressed as medians and interquartile ranges (IQRs) for continuous variables and as actual numbers and percentages for categorical variables. OS and PFS were calculated using the Kaplan–Meier method, and their statistical differences were evaluated using the log-rank test. Cox proportional hazard models were used to identify independent factors associated with PFS and OS.

The NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count from peripheral complete blood counts. The cutoff value of NLR’s predictive capability for radiological progressive disease was calculated using a receiver operating characteristic curve based on sensitivity and specificity using the Youden index [18]. Cutoff values for other factors such as age [19], AFP level [1], maximum tumor diameter, number of tumors [19, 20], Child–Pugh score, and mALBI grade [7, 21, 22] were based on previous studies.

Statistical significance was set at a P value of < 0.05. All analyses were performed using SPSS statistical software version 24.0 for Windows (IBM Corp., Armonk, NY, USA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A